
Vertero Therapeutics
Developer of a new class of biotherapeutics designed to treat neurological disorders. The company's products harness the gut-brain axis to develop a novel central nervous system that opposes diseases ...
Valuation
$48M
Latest known
Share Price
N/A
Total Raised
$111.2M
Last Round
N/A